ISSN: 1017-6616 e-ISSN: 2149-8059
Home Contact Login / Sign up
-Türkçe -English
header logo
header logo
  • Home
  • Aim and Scope
  • Guide for Authors
  • Editorial Boards
  • Current Issue
  • Archive
  • Submit Article
  • Contact Us
Home Aim and Scope Guide for Authors Editorial Boards Current Issue Archive Submit Article Contact Us
kapak cover
Vol:41 Issue:1 Year:2025
Current Issue Archive Ahead of Print Copyright Notification Review Process Editorial Boards Indexing Payment Policy Archiving and Data Sharing Policy Open Access Policy Reviewer and Editor Guidelines Logo Design and Story Ethical Principles and Publication Policy Article Submission Files Contact

Search Results

CURRENT TREATMENT OPTIONS FOR BONE METASTASES

EDA YİRMİBEŞOĞLU ERKAL, GÖRKEM AKSU

 PDF  Send an Email to Editor
PROGNOSTIC RISK FACTORS PREDICTING SURVIVAL IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH NIVOLUMAB

TANJU KAPAGAN, NILUFER BULUT, GOKMEN UMUT ERDEM

 PDF  Send an Email to Editor
EFFICACY OF BEVACIZUMAB-BASED TERAPY IN PATIENT WITH METASTATIC OR RECURRENT CERVICAL CANCER: REAL LIFE DATA

NIJAT KHANMAMMADOV, IZZET DOGAN, NECLA SİMAY OKAY, MUCAHIT UGAR, NARMINA OSMANOVA, PINAR SAİP, ADNAN AYDINER

 PDF  Send an Email to Editor
PRIMARY ANGIOSARCOMA OF BREAST

MUSTAFA U. KALAYCI, CEYHAN UĞURLUOĞLU, HAKAN BULAK, EROL EROĞLU, HÜSEYİN ERASLAN, SÜLEYMAN ORAL

 PDF  Send an Email to Editor
A BENIGN PATHOLOGY MIMICKING MULTIPLE BONE METASTASIS ON F-18 FDG-PET/CT: BROWN TUMOR

ÖZLEM DÜNDAR ŞAHİN, AHMET EREN ŞEN, ZEYNEP AYDIN, BUĞRA KAYA

 PDF  Send an Email to Editor
footer logo
Selçuk Tıp Dergisi

[email protected]
ISSN: 1017-6616
e-ISSN: 2149-8059

Site content (images, text and applications) cannot be used without citing the source. This site has been prepared to provide information in the published content areas. When using the information on the site, the responsibility lies entirely with the user. By entering the site, you are deemed to have read, understood and accepted these terms.

This system was prepared by Dijider.